MEASURIN Drug Patent Profile
✉ Email this page to a colleague
When do Measurin patents expire, and when can generic versions of Measurin launch?
Measurin is a drug marketed by Bayer and is included in one NDA.
The generic ingredient in MEASURIN is aspirin. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin profile page.
Summary for MEASURIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 136 |
Clinical Trials: | 9 |
Patent Applications: | 3,965 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MEASURIN at DailyMed |
Recent Clinical Trials for MEASURIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Roswell Park Cancer Institute | Phase 2 |
AIM ImmunoTech Inc. | Phase 2 |
Merck Sharp & Dohme Corp. | Phase 2 |
US Patents and Regulatory Information for MEASURIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer | MEASURIN | aspirin | TABLET, EXTENDED RELEASE;ORAL | 016030-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |